Mohammed Alo: The Gap Between Nattokinase Marketing and Evidence
Mohammed Alo, Fellow of the American College of Cardiology at American College of Cardiology, shared a post on LinkedIn:
“Nattokinase will not unclog your arteries.
Supplement companies are selling you a $40 bottle of false hope while your plaques keep growing.
But the data says otherwise.
And no, they are not just ‘natural enzymes that dissolve clots.’
What you are actually dealing with:
Atherosclerosis is not a kitchen drain clogged with grease. You cannot pour an enzyme down your coronary artery and watch the blockage dissolve.
Plaques are complex structures. Fibrous caps. Lipid cores. Calcified deposits. Inflammatory cells. A fermented soybean extract is not touching any of that.
Yet the online grifters are selling nattokinase as if it is the secret your cardiologist does not want you to know. They are wrong. And the silence from the cardiology literature is not a conspiracy. It is a verdict.
I am a board-certified cardiologist.
I am America’s Cardiologist.
I have treated thousands of patients with established coronary artery disease, acute MI, and high-risk atherosclerosis. I have never once seen nattokinase on a peer-reviewed guideline. Not in the ACC. Not in the AHA. Not anywhere that answers to evidence.
Here is what the science actually says:
The research on nattokinase comes almost entirely from rat studies and in vitro models. Rats are not humans.
Test tubes are not arteries. An enzyme that shows fibrinolytic activity in a petri dish does not automatically translate to clinical benefit in a living, breathing patient with decades of plaque burden.
The human trial data is thin, small, and nowhere near the scale required to make the claims supplement marketers are making.
We are talking about studies with dozens of participants, no cardiovascular outcome data, and zero evidence that nattokinase reduces heart attacks, strokes, or cardiovascular death.
That is not promising. That is not ’emerging.’ That is insufficient.
Now contrast that with what we actually know works.”

Stay updated with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience